Companies /Basic Materials

Green Plains Inc

NASDAQ: GPRE Chemicals

GPRE at a Glance

Valuation
Market cap
$927.4M
P/E ratio
5.4
Profitability
Revenue (TTM)
$1.8B
Profit margin
10.9%
EPS (TTM)
$2.46
Price
52-week range
$9 – $20
Street target
$18.50
Earnings
Next report
Feb 3, 2027

Headquartered in Omaha, NE Fiscal year ends December NASDAQ: GPRE gpreinc.com

About Green Plains

Green Plains Inc. (NASDAQ: GPRE) produces low-carbon biofuels and value-added agricultural products. It reports two operating segments:
- Ethanol production: production, storage and transportation of ethanol, distillers grains, Ultra-High Protein feed ingredients and renewable corn oil, plus carbon capture and sequestration (CCS) operations at its three Nebraska plants.
- Agribusiness and energy services: grain handling and storage, and commodity marketing and merchant trading of company-produced and third-party ethanol, distillers grains, renewable corn oil, natural gas and other commodities.

The company currently runs eight operating ethanol plants after disposing of its Obion, Tennessee facility. It focuses on maximizing yields and lowering carbon intensity to earn Section 45Z clean fuel production tax credits. Those credits have become a major earnings contributor and are being monetized through a credit transfer agreement. Updated

Latest Activity

GPREGreen Plains
Q3 2026
EPS
$1.03
est $0.62+67.0%
Revenue
$496M
est $530M-6.5%

The October 29 agreement to monetize $250 million to $325 million of Section 45Z credits turns tax policy into cash for a company worth under $1 billion. Management raised the full-year 45Z EBITDA contribution to $230 million to $250 million, and a $67.2 million credit booked against cost of goods sold delivered an EPS beat of 67% on revenue missing expectations.

Quarterly EPS — reported vs estimate

GPRE Coverage

Frequently Asked Questions

What does Green Plains do?

Green Plains Inc. (NASDAQ: GPRE) produces low-carbon biofuels and value-added agricultural products.

What is the GPRE stock price target?

The Wall Street consensus 12-month price target for GPRE is $18.50.